Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,797 | 220 | 96.5% |
| Travel and Lodging | $145.77 | 1 | 2.9% |
| Education | $26.83 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $648.01 | 18 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $585.61 | 26 | $0 (2024) |
| Astellas Pharma US Inc | $433.42 | 22 | $0 (2023) |
| Medtronic, Inc. | $432.22 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $273.65 | 13 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $239.96 | 15 | $0 (2023) |
| ABBVIE INC. | $232.80 | 15 | $0 (2024) |
| Amgen Inc. | $211.21 | 10 | $0 (2020) |
| UROGEN PHARMA, INC. | $169.86 | 6 | $0 (2024) |
| Antares Pharma, Inc. | $132.98 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $487.50 | 23 | Antares Pharma, Inc. ($86.75) |
| 2023 | $487.04 | 22 | Medtronic, Inc. ($103.96) |
| 2022 | $567.68 | 28 | UroGen Pharma, Inc. ($84.31) |
| 2021 | $442.81 | 12 | Medtronic, Inc. ($206.62) |
| 2020 | $136.93 | 5 | Medtronic USA, Inc. ($39.70) |
| 2019 | $1,090 | 55 | NeoTract Inc. ($328.99) |
| 2018 | $919.64 | 41 | NeoTract Inc. ($192.15) |
| 2017 | $837.56 | 38 | Bayer HealthCare Pharmaceuticals Inc. ($174.36) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Diagnostic Imaging | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/07/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/24/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $26.16 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/20/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $25.41 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 07/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Oncology | ||||||
| 06/14/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $54.44 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/07/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 06/06/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $13.66 | General |
| Category: Urology | ||||||
| 05/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Oncology | ||||||
| 05/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.65 | General |
| Category: Prostate cancer | ||||||
| 04/24/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $18.54 | General |
| Category: Prostate cancer | ||||||
| 03/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Oncology | ||||||
| 03/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/12/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 4,935 | 10,393 | $1.1M | $295,137 |
| 2022 | 45 | 5,283 | 11,841 | $1.2M | $318,661 |
| 2021 | 51 | 5,517 | 14,335 | $1.3M | $369,531 |
| 2020 | 51 | 4,694 | 10,286 | $951,647 | $221,205 |
All Medicare Procedures & Services
190 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 875 | 1,343 | $318,648 | $97,065 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 354 | 441 | $148,931 | $43,407 | 29.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 165 | 192 | $198,244 | $37,750 | 19.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 17 | 109 | $60,632 | $14,292 | 23.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 107 | 115 | $34,270 | $9,882 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 164 | 197 | $29,282 | $9,292 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $27,519 | $8,156 | 29.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 55 | 138 | $38,778 | $6,862 | 17.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 22 | 23 | $21,872 | $6,397 | 29.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 198 | 274 | $12,604 | $4,937 | 39.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 22 | 22 | $21,714 | $4,692 | 21.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 368 | 522 | $5,658 | $4,141 | 73.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 43 | 45 | $23,085 | $4,118 | 17.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 87 | 149 | $9,685 | $3,768 | 38.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 980 | 1,678 | $10,068 | $3,678 | 36.5% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 173 | 203 | $9,338 | $3,658 | 39.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 17 | 17 | $18,513 | $3,652 | 19.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 269 | 343 | $25,725 | $3,098 | 12.0% |
| 51705 | Simple change of bladder tube | Office | 2023 | 13 | 37 | $10,303 | $3,027 | 29.4% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 86 | 135 | $7,290 | $2,876 | 39.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 25 | 25 | $8,569 | $2,621 | 30.6% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 11 | 11 | $9,658 | $2,089 | 21.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 110 | 161 | $4,186 | $1,666 | 39.8% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 33 | 34 | $5,202 | $1,639 | 31.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 19 | 47 | $4,166 | $1,418 | 34.0% |
About Dr. Michael Solliday, MD
Dr. Michael Solliday, MD is a Urology healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285739235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Solliday, MD has received a total of $4,970 in payments from pharmaceutical and medical device companies, with $487.50 received in 2024. These payments were reported across 224 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($4,797).
As a Medicare-enrolled provider, Solliday has provided services to 20,429 Medicare beneficiaries, totaling 46,855 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 190 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Poughkeepsie, NY
- Active Since 09/14/2006
- Last Updated 01/29/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1285739235
Products in Payments
- UroLift (Device) $521.14
- INTERSTIM (Device) $506.97
- Xofigo (Drug) $332.94
- Nubeqa (Drug) $252.67
- MYRBETRIQ (Drug) $205.33
- XIAFLEX (Biological) $204.93
- Prolia (Biological) $185.64
- JELMYTO (Drug) $169.86
- Xtandi (Drug) $146.18
- PROVENGE (Drug) $138.01
- Urolift - UL400 (Device) $126.87
- ERLEADA (Drug) $126.23
- XTANDI (Drug) $120.19
- XYOSTED (Drug) $114.10
- ORGOVYX (Drug) $110.26
- KEYTRUDA (Biological) $107.54
- FIRMAGON (Drug) $100.82
- JATENZO (Drug) $92.21
- GEMTESA (Drug) $74.00
- Androgel (Drug) $71.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Poughkeepsie
Dr. Evan Goldfischer, Md, MD
Urology — Payments: $507,233
Walter Parker, Md, MD
Urology — Payments: $6,695
Dr. Scott Kahn, Md, MD
Urology — Payments: $4,478
Dr. Jason Krumholtz, Md, MD
Urology — Payments: $3,417
Dr. Mark Libin, Md, MD
Urology